LARA KROEPSCH: Open Payments
NPI 1902162084 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 71 payments from 21 companies in 2025. Trend: 2023 $1,159 · 2024 $1,442 · 2025 $1,577
Food & beverage: $1,577
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 16 | $253 |
| Lilly USA, LLC | 9 | $191 |
| PFIZER INC. | 6 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Lundbeck LLC | 4 | $116 |
| C2N Diagnostics, LLC | 4 | $99 |
| SK Life Science, Inc. | 3 | $83 |
| ABBVIE INC. | 5 | $81 |
| Eisai Inc. | 2 | $61 |
| ARGENX US, INC. | 2 | $57 |
Products named: BRIUMVI, AMYVID, NURTEC ODT, KESIMPTA, VYEPTI, PRECIVITYAD2, QULIPTA, Leqembi.
Industry payments across CO — which companies pay providers there.
